Antimicrobial-Resistant Campylobacter in the Food Chain in Mexico
- 1 September 2012
- journal article
- research article
- Published by SAGE Publications in Foodborne Pathogens and Disease
- Vol. 9 (9) , 841-847
Abstract
We describe prevalence and antimicrobial susceptibility results for thermophilic Campylobacter isolates collected from humans, food, and food-animals in an integrated food chain surveillance network in Mexico. From 2003 to 2006, stool samples were collected from children with diarrhea at state sentinel hospitals. Concurrently, fecal samples from asymptomatic children in kindergartens, as well as raw chicken, pork and beef from retail outlets, and food-animal intestines from slaughterhouses were all collected in 65 cities from four different states. C. jejuni was identified with a standardized hippurate test. Hippurate negative, indoxyl acetate positive isolates were classified as Campylobacter spp. Susceptibility testing was performed by agar dilution according to Clinical and Laboratory Standards Institute guidelines. A total of 1,259 C. jejuni and 1,797 Campylobacter spp. isolates were recovered from 11,811 samples. Chicken was significantly more contaminated for both intestinal samples (93.6%) and meat products (58.3%), compared with swine (71.4%)/pork (14.6%) samples, and cattle (25.1%)/beef (5.3%) samples (pCampylobacter was recovered from 5.1% of children with diarrhea and from 3.2% of asymptomatic children. Chicken was significantly more likely to harbor ciprofloxacin-resistant C. jejuni (85.8%) than swine (62.5%, OR=3.6), cattle (39.8%, OR=9.3), or humans (58.2%, OR=4.4). No significant differences were found for ciprofloxacin-resistant Campylobacter spp. among food-animals, but the rate in food-animals was significantly higher than in humans (84% vs. 56.7%, OR=4.0). Swine was significantly more likely to harbor erythromycin-resistant C. jejuni (14.8%) than chicken (3.5%, OR=4.9), cattle (1.8%, OR=9.3), or humans (3.0%, OR=5.7), and was associated with higher rates of erythromycin-resistant Campylobacter spp. (41.9%) than chicken (10.5%, OR=6.1) and humans (11.9%, OR=5.3). The high resistance rates to ciprofloxacin preclude the use of fluoroquinolones for treatment of campylobacteriosis in Mexico. Our results emphasize the need for ongoing and integrated surveillance of antimicrobial usage and antimicrobial susceptibility in humans and animals.Keywords
This publication has 22 references indexed in Scilit:
- Foodborne Illness Acquired in the United States—Major PathogensEmerging Infectious Diseases, 2011
- Antimicrobial Resistance of Campylobacter Isolates from Retail Meat in the United States between 2002 and 2007Applied and Environmental Microbiology, 2010
- Seasonal Variation of Enteropathogens in Infants and Preschoolers With Acute Diarrhea in Western MexicoJournal of Pediatric Gastroenterology and Nutrition, 2010
- Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors for Campylobacter Enteritis, EnglandEmerging Infectious Diseases, 2009
- Campylobacter spp. and their Antimicrobial Resistance Patterns in Poultry: An Epidemiological Survey Study in TurkeyZoonoses and Public Health, 2009
- Antibiotic Resistance in Campylobacter : Emergence, Transmission and PersistenceFuture Microbiology, 2009
- Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005BMC Infectious Diseases, 2008
- Integrated Food Chain Surveillance System for Salmonella spp. in Mexico1Emerging Infectious Diseases, 2008
- Campylobacter Antimicrobial Drug Resistance among Humans, Broiler Chickens, and Pigs, FranceEmerging Infectious Diseases, 2007
- CampylobacterTransmission in a Peruvian Shantytown: A Longitudinal Study Using Strain Typing ofCampylobacterIsolates from Chickens and Humans in Household ClustersThe Journal of Infectious Diseases, 2003